CJEU hands down SPC guidance in Royalty Pharma
30-04-2020
Questions on Neurim scope remain post-SPC ruling, say lawyers
25-03-2019
nitpicker / Shutterstock.com
The Court of Justice of the European Union (CJEU) yesterday, March 21, handed down a supplementary protection certificate (SPC) decision referred to it by the English High Court.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
CJEU, Court of Justice of the European Union, SPC, supplementary protection certificate, Abraxis, marketing authorisation, English High Court
